share_log

Bioasis Technologies Inc. (OTCMKTS:BIOAF) Short Interest Down 23.3% in July

Defense World ·  Aug 15, 2022 16:32

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the recipient of a significant decrease in short interest in the month of July. As of July 31st, there was short interest totalling 34,600 shares, a decrease of 23.3% from the July 15th total of 45,100 shares. Based on an average daily trading volume, of 29,000 shares, the short-interest ratio is presently 1.2 days.

Bioasis Technologies Stock Performance

BIOAF stock opened at $0.12 on Monday. The company's 50 day moving average price is $0.13 and its 200 day moving average price is $0.17. Bioasis Technologies has a fifty-two week low of $0.10 and a fifty-two week high of $0.28. The firm has a market capitalization of $9.50 million, a price-to-earnings ratio of -2.99 and a beta of 0.19.

Get Bioasis Technologies alerts:

Bioasis Technologies (OTCMKTS:BIOAF – Get Rating) last announced its quarterly earnings results on Tuesday, June 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. Equities analysts forecast that Bioasis Technologies will post -0.05 EPS for the current fiscal year.

Bioasis Technologies Company Profile

(Get Rating)

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases.

Featured Articles

  • Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
  • Here is a Simple 4 Stock Portfolio that Can Outperform the Market
  • Is AMC Entertainment Pulling a Fast One on the APEs?
  • Here's How the Inflation Reduction Act Energizes Power Stock
  • 2 Important Retail Stock Battles to Watch
  • MarketBeat: Week in Review 8/8 – 8/12

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment